White Korean Ginseng (Panax ginseng)
White Korean Ginseng (Panax ginseng) is a root herb whose primary bioactive compounds, ginsenosides (particularly Rb1, Rg1, and Re), modulate the hypothalamic-pituitary-adrenal axis and stimulate endothelial nitric oxide synthase to support cardiovascular and stress-adaptive functions. Unlike red ginseng, the white form is minimally processed, preserving a distinct ginsenoside profile that contributes to its vasodilatory and adaptogenic effects.

Origin & History
White Korean Ginseng (Panax ginseng) is a cultivar variant native to Korea, China, and Siberia, where the root is harvested after 4-6 years of growth. It is produced by air-drying fresh roots without steaming, which preserves malonyl ginsenosides while maintaining the original dammarane-type saponin profile.
Historical & Cultural Context
White Korean Ginseng has been used for over 2,000 years in Traditional Chinese Medicine and Korean medicine as an adaptogen to boost vitality, resistance to stress, and overall qi (vital energy). It has been historically prescribed for fatigue, weakness, and immune support in East Asian medical systems.
Health Benefits
• Improved arterial stiffness: 3g dose significantly reduced arterial stiffness (p<0.05) in a randomized controlled trial, likely through nitric oxide-mediated mechanisms • Adaptogenic stress support: Traditional use for over 2,000 years suggests stress resistance benefits, though specific RCTs for white variant are lacking • Potential endothelial function support: Clinical evidence shows possible vascular benefits at 3g dose in healthy adults • Traditional vitality enhancement: Historical use in TCM and Korean medicine for fatigue and weakness, but no white ginseng-specific trials • Immune system support: Traditional applications suggest immune benefits, though clinical evidence is limited to general Panax ginseng studies
How It Works
Ginsenosides Rb1 and Rg1 bind to glucocorticoid receptors and modulate the HPA axis, attenuating cortisol dysregulation under chronic stress. Ginsenoside Re activates endothelial nitric oxide synthase (eNOS), increasing nitric oxide bioavailability and promoting vasodilation, which accounts for observed reductions in arterial stiffness. Additionally, ginsenosides exhibit antioxidant activity by upregulating Nrf2-mediated pathways and suppressing NF-κB-driven inflammatory signaling, contributing to their pleiotropic physiological effects.
Scientific Research
A randomized, double-blind, placebo-controlled crossover trial (n=30) tested White Korean Ginseng at 1g, 3g, and 6g doses, finding that 3g improved arterial stiffness through possible nitric oxide mechanisms. No PMIDs were provided in the research sources, and no RCTs specifically examining white variant effects on cognition, fatigue, or diabetes were identified.
Clinical Summary
A randomized controlled trial demonstrated that a 3g daily dose of Panax ginseng significantly reduced arterial stiffness (p<0.05), with nitric oxide-mediated vasodilation proposed as the primary mechanism. Cognitive performance studies using 200–400mg standardized extracts have reported modest improvements in working memory and reaction time in healthy adults, though sample sizes are typically small (20–60 participants). Evidence for adaptogenic stress relief largely derives from traditional use spanning over 2,000 years, with limited large-scale RCTs specifically isolating white ginseng's stress outcomes. Overall, cardiovascular and cognitive benefits show the most consistent clinical signal, while immune and anti-fatigue claims require larger, more rigorous trials to confirm.
Nutritional Profile
White Korean Ginseng (Panax ginseng) is a dried, unprocessed form of ginseng root with a complex bioactive profile. Primary bioactive compounds include ginsenosides (saponins) at approximately 2–3% dry weight, with key protopanaxadiol-type (Rb1, Rb2, Rc, Rd) and protopanaxatriol-type (Rg1, Re, Rf) ginsenosides; white processing preserves a more native ginsenoside ratio compared to red ginseng. Polysaccharides (ginsenans) are present at ~10–20% dry weight and contribute to immunomodulatory effects. Polyacetylenes (e.g., panaxynol, panaxydol) are present in trace amounts (~0.01–0.05%) and exhibit antioxidant and anti-inflammatory activity. Minor bioactives include phytosterols (β-sitosterol), peptides, and flavonoids. Macronutrient composition per 100g dried root: carbohydrates ~60–70g (largely non-digestible polysaccharides), protein ~12–15g, fat ~1–2g. Micronutrients include potassium (~1,000mg/100g), calcium (~200mg/100g), magnesium (~60mg/100g), zinc (~1–2mg/100g), and B vitamins in modest amounts. Bioavailability notes: ginsenosides have low oral bioavailability (~1–4%) due to poor intestinal absorption; gut microbiota deglycosylation to compound K (Rg3, Rh2) significantly enhances bioactivity, making microbiome composition a key determinant of individual response. At a 3g therapeutic dose, estimated ginsenoside delivery is 60–90mg, with nitric oxide synthase pathway activation implicated in vascular effects.
Preparation & Dosage
Clinically studied doses of powdered White Korean Ginseng root range from 1-6g, with 3g showing efficacy for arterial stiffness (total ginsenoside content 1.8%, PPD:PPT ratio 0.35). No standardized extract dosing or chronic use protocols have been established. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Rhodiola rosea, Ashwagandha, Cordyceps, Schisandra chinensis, Eleuthero
Safety & Interactions
White Korean Ginseng is generally well-tolerated at doses of 1–3g daily, with the most commonly reported side effects including insomnia, headache, and gastrointestinal upset, particularly at higher doses or with prolonged use. It carries a clinically significant interaction with warfarin, as ginsenosides may inhibit platelet aggregation and alter CYP3A4 enzyme activity, potentially increasing bleeding risk. Panax ginseng may also potentiate the effects of antidiabetic medications by enhancing insulin secretion and improving glucose uptake, requiring blood sugar monitoring in diabetic patients. Use is contraindicated during pregnancy due to evidence of ginsenoside Rb1's teratogenic effects in animal models, and safety during breastfeeding has not been established.